RHB-204

· RedHill Biopharma Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RHB-204, covering 2025-03-18 to 2025-03-18. Get the full timeline:

Most recent: Clinical Trial Update: RHB-204 for the Treatment of Pulmonary Mycobacterium Avium Complex Disease [Phase 3]